• SteinCares has strengthened its product portfolio in Colombia through an expanded agreement with Pharmacosmos for the commercialization and distribution of Monofer®, an innovative intravenous iron replacement therapy.
• This alliance reinforces SteinCares’ leadership as a strategic partner for global companies seeking to enter the Latin American market, increasing access to innovative therapies.

San Jose, Costa Rica, August 2024 – SteinCares, a leading specialty healthcare company in Latin America, has expanded its exclusive licensing agreement with Pharmacosmos for Monofer® in Colombia. This innovative therapy addresses iron deficiency anemia, a condition that affects 25% of children under the age of 5 and half of pregnant women in Colombia.

“Our expanded partnership with Pharmacosmos underscores our commitment to providing Latin American patients with the best therapeutic options globally,” said Sebastian Katz, Chief Strategy Officer at SteinCares.

Monofer® is a high-dose intravenous iron-carbohydrate complex currently marketed in Asia, Europe, North America and Latin America, offering a new treatment alternative for iron deficient and anemic patients in Colombia.

About Pharmacosmos Group 

Pharmacosmos Group, headquartered in Holbaek, Denmark, and founded in 1965, is a highly specialised company focused on carbohydrate chemistry and a global leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia. With companies in the UK, Nordics, Germany, the USA, and China, as well as through partners, Pharmacosmos markets its products around the world. With a strong and ongoing commitment to R&D, Pharmacosmos is able to leverage a unique carbohydrate production platform along with deep expertise in the synthesis of iron-carbohydrate complexes. The Pharmacosmos Group has more than 600 employees. 

For more information, please visit https://www.pharmacosmos.com/

About SteinCares

SteinCares is a leader in commercializing and distributing specialty healthcare products in Latin America, including innovative pharmaceuticals, biosimilars and complex generics. With over 40 years of progressive healthcare experience and operations in over 30 countries in Latin America and the Caribbean, SteinCares serves as a bridge between global pharmaceutical companies and the region’s healthcare providers. The company is deeply committed to creating healthcare opportunities that positively impact the lives of patients and their families in Latin America, with a vision of increasing access to innovative and cost-effective healthcare for patients in the region.

For more information, visit http://www.steincares.com/ or follow the company on LinkedIn.